JWA
GMAB icon

JFS Wealth Advisors’s Genmab GMAB Stock Holding History

JFS Wealth Advisors’s Portfolio GMAB Stock Details GMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.49K Sell
127
-2
-2% -$53 ﹤0.01% 1428
2026
Q1 		$3.46K Hold
129
– – ﹤0.01% 1323
2025
Q4 		$3.97K Hold
129
– – ﹤0.01% 1326
2025
Q3 		$3.96K Hold
129
– – ﹤0.01% 1211
2025
Q2 		$2.67K Sell
129
-14
-10% -$287 ﹤0.01% 1309
2025
Q1 		$2.8K Buy
143
+139
+3,475% +$2.92K ﹤0.01% 1342
2024
Q4 		$84 Sell
4
-78
-95% -$1.71K ﹤0.01% 1894
2024
Q3 		$2K Sell
82
-59
-42% -$1.58K ﹤0.01% 1491
2024
Q2 		$3.54K Buy
141
+21
+18% +$595 ﹤0.01% 1206
2024
Q1 		$3.59K Sell
120
-124
-51% -$3.64K ﹤0.01% 1228
2023
Q4 		$7.77K Buy
244
+56
+30% +$1.76K ﹤0.01% 870
2023
Q3 		$6.63K Hold
188
– – ﹤0.01% 878
2023
Q2 		$7.15K Hold
188
– – ﹤0.01% 854
2023
Q1 		$7.1K Sell
188
-67
-26% -$2.58K ﹤0.01% 848
2022
Q4 		$10.8K Sell
255
-7
-3% -$288 ﹤0.01% 679
2022
Q3 		$8K Buy
262
+239
+1,039% +$8.39K ﹤0.01% 805
2022
Q2 		$1K Sell
23
-151
-87% -$4.89K ﹤0.01% 1534
2022
Q1 		$6K Buy
174
+129
+287% +$4.43K ﹤0.01% 968
2021
Q4 		$2K Sell
45
-62
-58% -$2.58K ﹤0.01% 1083
2021
Q3 		$5K Buy
+107
New +$4.8K ﹤0.01% 714
2020
Q2 		– Sell
-100
Closed -$2K – 543
2020
Q1 		$2K Sell
100
-900
-90% -$20.1K ﹤0.01% 440
2019
Q4 		$22K Hold
1,000
– – 0.01% 298
2019
Q3 		$20K Buy
+1,000
New +$19.7K 0.01% 302

Other funds holding GMAB

PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

JFS Wealth Advisors's GMAB Position: Q2 2026 in Review

JFS Wealth Advisors reduced its Genmab (GMAB) stake by 1.6% in Q2 2026, selling an estimated $53 and leaving 127 shares worth $3.49K. The position accounts for ﹤0.01% of the portfolio, ranked #1428.

JFS Wealth Advisors first reported a position in GMAB in Q3 2019 and has held it in 23 quarters since. The position peaked at $22K in Q4 2019. 289 funds tracked by Wall St. Rank hold GMAB as of Q2 2026.

  • JFS Wealth Advisors held 127 shares of Genmab worth $3.49K as of Q2 2026.
  • JFS Wealth Advisors sold 2 Genmab shares in Q2 2026, an estimated $53.
  • Genmab made up ﹤0.01% of JFS Wealth Advisors's portfolio in Q2 2026, its #1428 holding.
  • JFS Wealth Advisors first reported a position in Genmab in Q3 2019 and has held it in 23 quarters since.
  • JFS Wealth Advisors's Genmab position peaked at $22K in Q4 2019.
  • 289 funds tracked by Wall St. Rank held Genmab as of Q2 2026.

Based on JFS Wealth Advisors's 13F filing for Q2 2026, filed 10 Jul 2026.